Furthermore, analysis of public data from 81 ESCC cases using the Kaplan–Meier Plotter revealed that recurrence-free survival was significantly shorter in the TLR4 high-expression group than in the low-expression group (p = 0.026) (Figure S3A). The gene discussed is TLR4; the disease is esophageal squamous cell carcinoma.